Degradable magnesium-based implant devices for bone fixation

US11696976B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11696976-B2
Application numberUS-201615750219-A
CountryUS
Kind codeB2
Filing dateAug 22, 2016
Priority dateAug 21, 2015
Publication dateJul 11, 2023
Grant dateJul 11, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to biodegradable, magnesium alloys, compositions and composites, methods for their preparation and applications for their use as implantable medical devices in load-bearing conditions. The magnesium alloys are composed of alloying elements selected from yttrium, calcium, zirconium, zinc, and strontium, with the remainder being magnesium and impurities due to production, and are prepared by melting together the elements and casting the resulting melted mixture. In certain embodiments, the methods of preparation include solution treatment and hot extrusion.

First claim

Opening claim text (preview).

The invention claimed is: 1. An orthopedic or craniofacial bone fixation component composed of an extruded biodegradable, magnesium alloy, consisting of: from 0.5 weight percent to 4.0 weight percent of yttrium; from greater than zero to 1.0 weight percent of calcium; from 1.0 weight percent to 6.0 weight percent of zinc; from greater than zero to 1.0 weight percent of zirconium; from 0.10 weight percent to 6.0 weight percent of strontium; and a balance of magnesium and impurities due to production, based on total weight of the alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod, and intramedullary pin, and wherein the extruded biodegradable, magnesium alloy has formed precipitates arranged in a long period stacking order. 2. An orthopedic or craniofacial bone fixation component composed of an extruded biodegradable, magnesium alloy, consisting of: from 1.0 weight percent to 6.0 weight percent of zinc; from greater than zero to 1.0 weight percent of zirconium; optionally from greater than zero to 6.0 weight percent of strontium; optionally from 1.0 weight percent to 9.0 weight percent aluminum; optionally from 0.1 weight percent to 1.0 weight percent of manganese; optionally from 0.25 weight percent to 1.0 weight percent of silver; optionally from 0.1 weight percent to 1.0 weight percent of cerium; and a balance of magnesium and impurities due to production, based on total weight of the alloy, wherein the orthopedic or craniofacial bone fixation component is selected from the group consisting of Kirschner wire, cerclage wire, intramedullary rod and intramedullary pin, and wherein the extruded biodegradable, magnesium alloy has formed precipitates arranged in a long period stacking order.

Assignees

Inventors

Classifications

  • A61L31/148Primary

    Materials at least partially resorbable by the body · CPC title

  • with zinc or cadmium as the next major constituent · CPC title

  • Metals or alloys · CPC title

  • for reconstruction of bones; weight-bearing implants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11696976B2 cover?
The invention relates to biodegradable, magnesium alloys, compositions and composites, methods for their preparation and applications for their use as implantable medical devices in load-bearing conditions. The magnesium alloys are composed of alloying elements selected from yttrium, calcium, zirconium, zinc, and strontium, with the remainder being magnesium and impurities due to production, an…
Who is the assignee on this patent?
Univ Of Pittsburgh—Of The Commonwealth System Of Higher Education
What technology area does this patent fall under?
Primary CPC classification A61L31/148. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).